Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Fonds Vives II (University of Louvain, UCL), startups are often financed by Wallonia Regional Government, SFPI-FPIM, S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, S.R.I.W., Fund+. In the next rounds fund is usually obtained by curative ventures, SFPI-FPIM, S.R.I.W..
Among the most successful fund investment fields, there are Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight ITeos Therapeutics, A-Mansia Biotech. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
Related Funds
| Fund Name | Location |
| Bio Capital Impact Fund | Australia, Melbourne, Victoria |
| Bio Ritmo | Brazil, São Paulo, Sao Paulo |
| Chimera Investment | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Energiefonds Utrecht | Netherlands, Utrecht, Utrecht |
| Kaplan EdTech Accelerator | New York, New York, United States |
| Laurel Capital Partners | Pennsylvania, Radnor, United States |
| MoneyLion | New York, New York, United States |
| Synergy Growth | England, London, United Kingdom |
| Weed Ventures | - |
| Ziyu Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sunrise | $7M | 15 Dec 2021 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Virovet | $7M | 28 May 2020 | Leuven, Flemish Brabant, Belgium | ||
ITeos Therapeutics | $75M | 20 Jun 2018 | Cambridge, Massachusetts, United States | ||
A-Mansia Biotech | $15M | 27 Apr 2018 | Limburg | ||
ITeos Therapeutics | $10M | 03 May 2012 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sunrise | $7M | 15 Dec 2021 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium | ||
Virovet | $7M | 28 May 2020 | Leuven, Flemish Brabant, Belgium | ||
ITeos Therapeutics | $75M | 20 Jun 2018 | Cambridge, Massachusetts, United States | ||
A-Mansia Biotech | $15M | 27 Apr 2018 | Limburg | ||
ITeos Therapeutics | $10M | 03 May 2012 | Cambridge, Massachusetts, United States |
